EUVIMED · CrossrefJournal
Clinical Lung Cancer
ISSN 1525-7304 · Elsevier BV
Latest articles
Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-Year Update
Stage I Lung Adenocarcinoma in Young Patients (Aged ≤ 50 Years): Beyond Female Nonsmokers
Clinical And Radiological Predictors of Pathological Response to Chemo-Immunotherapy in Surgically Resected Non-Small Cell Lung Cancer
Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)
Risk of Developing a Subsequent Primary Lung Cancer Among Adult Non-Lung Cancer Survivors: Implications for Lung Cancer Screening and Supportive Care
Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting
Restoration of Lung Cancer Treatment After Successful Management of Aplastic Anemia: A Report of Two Cases Including a Case of Osimertinib Rechallenge
De Novo Lung Cancer after Lung Transplantation: Rethinking Surveillance and Early Detection
Comparative Effectiveness of First-Line Tyrosine Kinase Inhibitors in ALK-Positive Metastatic Non–Small Cell Lung Cancer by Presence of Brain Metastases
Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study
Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD
The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib
Assessment of Prognostic Value of CEACAM5 Expression Using Archival Tissue and Real-World Evidence of Metastatic Patients with NSCLC in United States
Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review
Racial Disparities in Thymic Epithelial Tumors: Insights From a Multiracial Urban Cohort
A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)
Corrigendum to “Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer” [Clinical Lung Cancer 26 (2025) 573-582]
Utility of longitudinal serum tumor markers for disease monitoring in advanced NSCLC with actionable genomic alterations
Safety and Efficacy of Stereotactic body radiotherapy for central and ultracentral Early-Stage Lung Tumors: A Canadian Provincial Cancer Center Experience.
Transforming the Therapeutic Landscape of HER2-Mutant NSCLC: Emerging First-Line Treatment Strategies
SAARC Consensus Recommendations for the diagnosis and treatment of non-small-cell lung cancer (NSCLC)
Local Failure after Consecutive Versus Nonconsecutive Stereotactic Body Radiotherapy for Early-Stage NSCLC: A Systematic Review and Meta-analysis
Beyond Segmentectomy: Stereotactic Body Radiotherapy as a First-Line Option Alongside Surgery for Subsolid Lung Cancer
Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study
Value of 18F-FDG PET/CT to Predict PD-L1 Expression and Prognosis in Advanced Thymic Squamous Cell Carcinoma
Real-world recurrence patterns and patient outcomes after 2 years of pembrolizumab immunotherapy in advanced non-small cell lung cancer.
Tarlatamab-Associated Pain Crisis: A Multi-Institutional Case Series
Cardiac Arrhythmias after Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Net survival and cause-specific mortality after lung cancer resection in octogenarians
EUVIMED